Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease

Neurological Research

Volumn 25, Issue 6, 2003, Pages 605-610

  Miklossy, Judith ^a,b  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid angiopathy; Arterial hypotension; Cerebral hypoperfusion; Vascular disease; Watershed cortical infarct

Indexed keywords

NEUROLEPTIC AGENT; SEDATIVE AGENT;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN PERFUSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HYPOTENSION; LEUKOARAIOSIS; NERVE DEGENERATION; REVIEW; VASCULAR DISEASE;

ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; HUMANS; HYPOTENSION;

EID: 0042388002     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103101202048     Document Type: Review

References (63)

1. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733-736
2. Hachinski V, Munoz DG. Cerebrovascular pathology in Alzheimer's disease: Cause, effect or epiphenomenon? Ann NY Acad Sci 1997; 826: 1-6
3. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stage of Alzheimer's disease. Lancet 1999; 354: 919-920.
4. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study. JAMA 1997; 277: 813-817
5. De Jong GI, De Vos RA, Steur EN, Luiten PG. Cerebrovascular hypoperfusion: A risk factor for Alzheimer's disease? Animal model and postmortem human studies. Ann NY Acad Sci 1997; 826: 56-74.
6. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: Can it cause Alzheimer's disease? Ann NY Acad Sci 2000; 903: 424-436
7. de la Torre JC. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. Alzheimer Dis Assoc Disord 2000; 14: S72-81
8. de la Torre JC. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann NY Acad Sci 2000; 924: 136-152
9. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000; 21: 321-330
10. Waldemar G, Bruhn P, Kristensen M, Johnsen A, Paulson OB, Lassen NA. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a[99mTc]-d,I-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994; 57: 285-295
11. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94
12. Bokde AL, Pietrini P, Ibanez V, Furey ML, Alexander GE, Graff-Radford NR, Rapoport SI, Schapiro MB, Horwitz B. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. Arch Neurol 2001; 58: 480-486
13. O'Brien JT, Eagger S, Syed GM, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992; 55: 1182-1187
14. Kawamura J, Meyer JS, Ichijo M, Kobari M, Terayama Y, Weather S. Correlation of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. J Neurol Neurosurg Psychiatry 1993; 56: 182-187
15. Hachinski VC, Potter P, Merskey H. Leuko-araiosis: An ancient term for a new problem. Can J Neurol Sci 1986; 13: S533-534
16. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987; 44: 21-23
17. Johnson K, Mueller S, Walshe T, English R, Holman B. Cerebral perfusion imaging in Alzheimer's disease. Arch Neurol 1987; 44: 165-168
18. Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H. Neuropathologic correlates of leuko-araiosis. Arch Neurol 1989; 46: 1124-1128
19. Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy and cognition. Am J Neuroradiol 1990; 11: 273-281
20. Mirsen TR, Lee DH, Wong CJ, Diaz JF, Fox AJ, Hachinski VC, Merskey H. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 1991; 48: 1015-1021
21. Diaz JF, Merskey H, Hachinski VC, Lee DH, Boniferro M, Wong CJ, Mirsen TR, Fox H. Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. Arch Neurol 1991; 48: 1022-1025
22. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. Stroke 1995; 26: 1293-1301
23. Pantoni L, Garcia JH. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann NY Acad Sci 1997; 826: 92-102
24. Prencipe M, Marini C. Leuko-araiosis: definition and clinical correlates - An overview. Eur Neurol 1989; 29: S27-29
25. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 1986; 19: 253-262
26. Kawamura J, Meyer JS, Terayama Y, Weatgers S. Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia. J Am Geriatr Soc 1992; 40: 375-380
27. Kawamura J, Meyer JS, Ichijo M, Kobari M, Terayama Y, Weather S. Correlation of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. J Neurol Neurosurg Psychiatry 1993; 56: 182-187
28. Ishijima M, Imazu O, Kitamura S, Terashi A. Clinico-pathological evaluation of leukoaraiosis in Alzheimer's disease. J Geriatrics 1996; 33: 774-753
29. Prohovnik J, Mayeux R, Sackeim HA, Smith G, Stern Y, Alderson PO. Cerebral perfusion as a diagnostic marker of early Alzheimer's disease. Neurology 1988; 38: 931-937
30. Pavics L, Grunwald F, Reichmann K, Horn R, Kitschenberg A, Hartmann A, Menzel C, Schomburg AG, Overbeck B, Csernay L, Biersack HJ. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test and Alzheimer's dementia. Eur J Nucl Med 1999; 26: 239-245
31. Nagata K, Sato M, Satoh Y, Watahiki Y, Kondoh Y, Sugawara M, Box G, Wright D, Leung S, Yuya H, Shimosegawa E. Hemodynamic aspects of Alzheimer's disease. Ann NY Acad Sci 2002; 977: 391-402
32. Nagata K, Maruya H, Yuya H, Terashi H, Mito Y, Kato H, Sato M, Satoh Y, Watahiki Y, Hirata Y, Yokoyama E, Hatazawa J. Can PET data differentiate Alzheimer's disease from vascular dementia? Ann NY Acad Sci 2000; 903: 252-261
33. Obara K, Meyer J.S, Kawamura J, Weathers S, Mortel KF. Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer type. J Neurol Sci 1994; 126: 96-102
34. Besson JA, Crawford JR, Parker DM, Ebmeier KP, Gemmel HG, Sharp PF, Best PV, Smith FW. Neuroimaging, cognitive and pathological changes in Dementia of Alzheimer Type (DAT). Psychiatry Res 1989; 29: 447-448
35. Bladin CF, Chambers BR. Clinical features, pathogenesis and computed tomographic characteristics of internal watershed infarction. Stroke 1993; 24: 1925-1932
36. Pentschew A. Die granuläre Atrophie der Grosshirnrinde. Arch Psychiatry 1933; 101: 80-136
37. Lindenberg R, Spatz H. Ueber die Thromboendarteriitis obliterans der Hirngefässe (Cerebrale Form der versus Winiwarter-Buergerschen Krankheit). Wirch Arch Pathol Anat Physiol 1939; 305: 531-557
38. Suter OC, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, Miklossy J. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002; 33: 1986-1992
39. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease brain. Prog Neurobiol 2001; 64: 575-611
40. Farkas E, De Vos RA, Jansen Steur EN, Luiten PG.Are Alzheimer's disease, hypertension, and cerebrocapillary damage related? Neurobiol Aging 2000; 21: 235-243
41. Kalaria RN. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 2002; 13: S48-52
42. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: Amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998; 153: 725-733
43. Weller RO, Massey A, Kuo YM, Roher AE. Cerebral amyloid angiopathy: Accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann NY Acad Sci 2000; 903: 110-117
44. Kalaria RN, Pax AB. Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res 1995; 705: 349-352
45. Gallyas F. Silver staining of collagen and reticulin fibres and cerebral capillaries by means of physical development. J Microsc 1970; 91: 119-124
46. Kalaria RN, Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport 1995; 6: 477-480
47. Regli F, VonSattel JP, Perentes E, Assal G. L'angiopathie amyloïde cérébrale. Rev Neurol 1981; 137: 181-194
48. Okazaki H, Reagan TJ, Campbell RJ. Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979; 54: 22-31
49. Vonsattel JPG, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study. Ann Neurol 1991; 30: 637-649
50. Thaddeus IM. Cerebral amyloid angiopathy: The vascular pathology and complications. J Neuropathol Exp Neurol 1986; 45: 79-90
51. Kalaria RN, Hedera P. beta-Amyloid vasoactivity in Alzheimer's disease. Lancet 1996; 347: 1492-1493
52. Suo Z, Su G, Placzek A, Kundtz A, Humphrey J, Crawford F, Mullan M. A beta vasoactivity in vivo. Ann NY Acad Sci 2000; 903: 156-163
53. Townsend KP, Obregon D, Quadros A, Patel N, Volmar Ch, Paris D, Mullan M. Proinflammatory and vasoactive effects of abeta in the cerebrovasculature. Ann NY Acad Sci 2002; 977: 65-76
54. de la Monte SM, Sohn YK, Etienne D, Kraft J, Wands JR. Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease. Ann NY Acad Sci 2000; 903: 61-71
55. Pasquier F, Leys D. Blood pressure and Alzheimer's disease. Rev Neurol 1998; 154: 743-751
56. Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P, Lewington G, Cunningham VJ, Rossor MN. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995; 186: 17-20
57. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41: 1155-1162
58. Huang C, Wahlund LO, Svensson L, Winblad B, Julin P. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment BMC Neurology 2002; 2: 9
59. McKhann GM, Grega MA, Borowicz LM Jr, Bechamps M, Selnes OA, Baumgartner WA, Royall RM. Encephalopathy and stroke after coronary artery bypass grafting: Incidence, consequences, and prediction. Arch Neurol 2002; 59: 1422-1428
60. Goldsmith HS. Omental transposition to the brain for Alzheimer's disease. Ann NY Acad Sci 1997; 826: 323-336
61. Goldsmith HS. Treatment of Alzheimer's disease by transposition of the omentum. Ann NY Acad Sci 2002; 977: 454-467
62. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging 2000; 21: 331-342
63. Soneira CF, Scott TM. Severe cardiovascular disease and Alzheimer's disease: Senile plaque formation in cortical areas. Clin Anat 1996; 9: 118-127